26 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Amyloidosis Foundation 2013 Senior Research Grant
History of the Amyloidosis Foundation: The Amyloidosis Foundation is a result of the merge of the Amyloidosis Research Foundation and the Amyloidosis Support Network in 2007. The ARF’s original mission was to support research for all types of amyloidosis and the ASN’s original mission was to increase awareness of the disease and support patients with information. The new organization maintains both missions with the intent of expanding our services to both patients and the medical and scientific community.
The grant program supports two research areas, basic scientific research and translational research. Applicants will have completed their doctoral studies or clinical fellowship more than ten (10) years prior to application to this program. Although a mentor is not a requirement, the involvement of one will be considered in the feasibility review of the proposal.
Complete applications must be received by August 1, 2013. You will receive a confirmation email or fax from the AF upon receipt of your application.
Selection and Considerations
The selection of the recipient(s) will be made by the Board of Directors of the foundation, after all applications have been reviewed by the Scientific Advisory Board, consisting of experts in the field of amyloidosis. Candidates are strictly prohibited from contacting any members of the advisory board regarding status of their application.
The committee will consider most favorably those proposals that provide evidence of an applicant’s research initiative and creativity. The committee will also consider the feasibility of meaningful results from the proposed research, and the likely contribution to the advancement of knowledge of Amyloidosis etiology, diagnosis, treatment, or prevention.
All candidates will receive notification from the AF office of the final selection of the recipient(s) via email or mail. The award announcement for this grant cycle will be no later than December 1, 2013.
Award Conditions and Reporting
The monetary award of $100,000US will be provided to the awardee's sponsoring institution in two payments of $50,000US for the direct support of the recipients work during the award year, which will begin January 1, 2014. Acknowledgement of receipt of the funds and date of receipt is required of the sponsoring institution.
At the mid point of the year, a brief update report must be submitted to the AF. This report is required prior to the release of the remaining funds. At the conclusion of the award year, the recipient is required to submit a brief written summary of the research conducted.
Recipients are expected to credit the foundation in any publications or presentations that result from the funded research.
Amyloidosis Foundation, Inc.
7151 N. Main St. Suite 2
Clarkston, MI 48346
Amyloidosis Foundation 2013 Junior Research Grant
The grant program supports two research areas, basic scientific research and translational research. Applicants will have completed their doctoral studies or clinical fellowship within ten (10) years prior to application to this program. Although a mentor is not a requirement, the involvement of one will be considered in the feasibility review of the proposal.
The monetary award of $50,000US will be provided to the awardees sponsoring institution in two payments of $25,000US for the direct support of the recipients work during the award year, which will begin January 1, 2014. Acknowledgement of receipt of the funds and date of receipt is required of the sponsoring institution.
Call for Proposals: NCL Research Award for Research on Batten Disease
The NCL Foundation provides regulary the NCL research award. The goal is to find a cure against the deadly children's disease Neuronal Ceroid Lipofuscinosis (NCL), also called Batten disease. This metabolic disorder is the most common neurodegenerative disease of childhood and is inevitably fatal. The gradual stages of the suffering are blindness, dementia, epilepsy, loss of speech, paralysis and complete helplessness.
We invite medical and basic science researchers worldwide to submit innovative clinical oriented or translational basic science projects, which can contribute to finding a cure for juvenile NCL.
Scientists from related areas of science including Alzheimer's disease, aging, and other lysosomal storage disorders, are particularly encouraged to apply with the aim to extend the NCL research community in move more efficiently towards a cure for NCL.
NCL Research Award 2013
This year, the NCL Foundation offers for the fifth time the NCL Research Award.
Grant monies (100,000 euros) are to be used for a postdoctoral fellowship in order to undertake the research project. In this fashion our goal is to promote the next generation of young NCL research scientists.
The deadline for applications: October 31, 2013
Please send the required documents to: Research@ncl-foundation.com
Request for Proposals: Global Foundation for Peroxisomal Disorders Small Grants Program
The GFPD is pleased to announce the availability of small grants. Grants are designed to assist investigators in obtaining preliminary findings, testing “proof of concept,” or conducting other research activities designed to prepare and support competitive, full-scale grant applications related to Peroxisomal Biogenesis Disorder – Zellweger Spectrum Disorder (PBD-ZSD).
Clinicians and researchers qualified in any aspect of PBD-ZSD may apply. The application should contain aims that are specific to PBD-ZSD. The period of the award will be up to 2 years in length, starting September 1st of the year that the application was submitted. Awards will be made up to $25,000 annually for direct costs. All applications will be critiqued and scored by an independent grant review board comprised of GFPD board members and independent medical and scientific personnel. Application deadline is June 14th, 2013.
Friday, June 14, 2013 is the due date for all applications. Submissions by mail must be postmarked no later than June 14, 2013. Emailed applications must be received by 9:00 p.m. EST on June 14, 2013.
Applications may be submitted electronically as a PDF to firstname.lastname@example.org. Please compile and send all the materials in the order requested in the Grant Application Instructions. Please retain a copy of your application for your files, in case there is a problem with your submission.
You will receive an acknowledgement of your application. If you do not hear from the GFPD confirming your application submission, please contact us at email@example.com or firstname.lastname@example.org.
Applications may also be submitted by regular mail. Please send the original application and 5 additional copies of it to:
The Global Foundation for Peroxisomal Disorders
5147 S. Harvard Avenue, Suite 181
Tulsa, OK 74135
Call for Applications: Genzyme 2013 Patient Advocacy Leadership Awards for Those With Lysosomal Storage Disorders
The Genzyme PAL Awards grants program was launched in 2011 to encourage bold new ideas and programs to support the LSD community worldwide. The PAL program funds innovative projects in disease awareness and education, community mobilization, non-profit development and good governance activities, patient care and support programs. Overwhelmingly successful in its first two years, Genzyme is pleased to be accepting proposals from LSD and rare disease patient organizations for 2013.
As a result of the incredible response from the global patient community, several important and exciting updates have been made to the program. First, the overall pool of funds available through the program was increased in 2012 to $100,000. In addition, Genzyme has streamlined the application process such that all applicants are now eligible to receive an award of up to $15,000 regardless of the age of the organization.
The PAL Awards represents Genzyme’s ongoing commitment to LSD patient organizations and to the rare disease community worldwide. PAL grants carry a maximum of $15,000. Completed applications must be submitted no later than June 7, 2013. Awards will be announced by September 30, 2013.
We strongly encourage all applicants to apply online.
Call for Applications: Benign Essential Blepharospasm Research Foundation Fellowship Program
Blepharospasm, a form of focal dystonia, is a chronic, unremitting, bilateral, forcible closure of the eyelids. Sometimes the spasms that start in the eyelid muscles extend further down into the lower face, causing uncontrolled contractions of the jaw or tongue. This condition is called oromandibular dystonia (Meige Syndrome).
Blepharospasm is a rare disease with the incidence from 1 in 10,000 to 1 in 25,000, but it is related to other adult onset focal dystonias such as cervical dystonia (spasmodic torticollis), spasmodic dysphonia and focal hand dystonia (such as writer's and musician's cramp). Physicians and scientists who are knowledgeable about these conditions are needed and a fellowship training program will address this need by training and encouraging young investigators.
The Benign Essential Blepharospasm Research Foundation (BEBRF) is pleased to offer a research fellowship to support the training of exceptionally qualified physicians or scientists who wish to focus on blepharospasm with and without oromandibular dystonia. Fellowships will be awarded in the amount of up to $75,000 per year for two years. The training program should focus on research into new treatments, pathophysiology or the genetics of benign essential blepharospasm and oromandibular dystonia. Research into photophobia, dry eye, and apraxia of the eyelid opening as they relate to benign essential blepharospasm and oromandibular dystonia will also be considered for funding. Involvement in the activities of the Dystonia Coalition and participation in one or more annual BEBRF Symposiums will also be required.
Physician applicants must be board certified or board eligible in neurology or ophthalmology, have completed a residency, and hold or be able to hold an unrestricted license to practice medicine in the United States. PhDs should have completed their degree. Applicants will need to describe their research plans in detail, and clinicians will need to describe their clinical training as well. Applicants must select a mentor at an institution who will be willing to sponsor the applicant and will help develop a training program for the fellow. The institution must provide information on their training environment, program curriculum, and available resources. Non-U.S. citizens working at institutions either in the USA or abroad are also eligible to apply for a fellowship.
Deadline to apply for this year's fellowship is June 30, 2013 for a fellowship to begin approximately on July 1, 2014. Decisions will be announced on August 31, 2013. Applications must be submitted via e-mail to email@example.com.
Sjögren’s Syndrome Foundation Research Grants Program
The Sjögren’s Syndrome Foundation strives to foster research that will have the greatest potential impact on Sjögren’s patients, ensuring new therapeutics are developed and a cure found.
One important way in which we strive for change is to promote innovative research that will have the greatest impact on the lives of those who have this prevalent and devastating disease. We want to help spur the research community to generate fresh ideas that will bring novel approaches to treatment and the development of new therapeutics and lead to a cure. The SSF currently focuses on many initiatives to reach this goal, including: the development of Clinical Practice Guidelines, the launching of a Clinical Trials Consortium, advocacy among federal research entities, and through the SSF Research Grants Program.
The SSF Research Grants Program places a high priority on both clinical and basic scientific research into the cause, prevention, detection, treatment, and cure of Sjögren’s, with support provided to investigators at every career level from student to junior investigator to senior-level leader.
SSF Research Funding Priorities
Innovation is key for all SSF research funding. We must inspire new ideas and the gathering of data necessary to determine if those ideas are viable so that investigators can take a risk to pursue a concept that could prove to be a major breakthrough in Sjögren’s.
Funding decisions for SSF grants will be based on the following priorities:
• Innovative and creative concepts
• Novel diagnostics and relevance to the SSF Breakthrough Goal
• Direct relevance to Sjögren’s
• High quality science
• Preliminary data; probability of SSF seed money leading to an NIH grant
• Potential practical importance through the use of human tissues or blood samples
• Outcome could define new therapeutic target in SS
• Collaborative aspects of project
• Focused and achievable in the time lines
• Author on peer-reviewed articles
• A young investigator who has already displayed a productive commitment to SS research and a potential career in the field
• Letters of recommendation (if required) praise commitment, focus, high standards and excellence Financial support important for the salary support and execution of the research
•Excellent lab environment and mentorship available if young investigator
Grants will be awarded in amounts ranging between $15,000 and $50,000 a year for two years, depending on satisfactory progress. A human study that reviewers deem to be the most innovative project will be eligible for a $50,000 grant. All investigators will submit a budget for$35,000 and revise the budget once an award offer is accepted.
SSF research grants are open to basic and clinical scientists holding an advanced degree (MD, DDS, DMD, or PhD) at any U.S. university or research institution. Both junior and senior investigators may apply. For physicians, advanced clinical training in a specialty related to Sjögren’s, such as rheumatology or ophthalmology, is desirable.
The application receipt deadline is February 1 each year. The grant funding period is July 1 through June 30.
Sjögren's Syndrome Foundation
6707 Democracy Boulevard
Bethesda, MD 20817
Toll Free: (800) 475-6473
Local call: (301) 530-4420
Fax: (301) 530-4415
National Ataxia Foundation Pioneer Spinocerebellar Ataxias Translational Research Award
The National Ataxia Foundation (NAF) is committed to funding the best science relevant to hereditary and sporadic types of ataxia in both basic and translational research. Funding for Ataxia-Telangiectasia research proposals will receive a lower priority unless they lend themselves to an overall better understanding of the ataxia disease process.
Pioneer SCA Translational Research Award: Three (3) one-year grants of $100,000 focusing on research investigations that will facilitate the development of treatments for the Spinocerebellar Ataxias (SCAs) will be awarded.
A Letter of Intent is REQUIRED prior to submitting a Pioneer Grant application. Pioneer Grant Applications submitted that were not preceded by a Letter of Intent, will NOT be reviewed.
August 15, 2013 - Letter of Intent with a ½ to one-page abstract with specific aims of your research.
September 15, 2013 - Full application due
Need More Information?
National Ataxia Foundation
2600 Fernbrook Lane Suite 119
Minneapolis, MN 55447-4752
Fax: (763) 553-0167
National Ataxia Foundation Research Post-Doc Fellowship Award
Research Post-Doc Fellowship Award: One-year grant up to $35,000. Applicants should have completed at least one year of post-doctoral training, but not more than two at the time of application, and should have shown a commitment to research in the field of ataxia.
August 15, 2013 - Letter of Intent with a ½ to one-page abstract with specific aims of your research
National Ataxia Foundation Young Investigator Awards
Young Investigator (YI) Award: One-year grant of $35,000 — $50,000 to encourage young investigators to pursue a career in the field of any form of ataxia research.
Young Investigator (YI-SCA) Award for SCA Research: Three (3) one-year grants of $50,000 will be awarded to encourage young investigators to pursue a career in spinocerebellar ataxia (SCA) research.
For both Young Investigator programs, candidates must have attained an MD or PhD degree, and have an appointment as a junior faculty member, senior post-doc or clinical fellow. Individuals at the Associate Professor level are not eligible. Clinicians must have finished their residency no more than five years prior to applying. PhDs must be no more than five years from end of the completion of their post-doc training.
The sponsoring institution must agree in writing to the following provision: the young investigator (MD or PhD) must be free to allocate approximately half time (50%) for ataxia related research.
August 1, 2013 - Letter of Intent with a ½ to one-page abstract with specific aims of your research
September 1, 2013 - Full application due